NO991910L - Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer - Google Patents

Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer

Info

Publication number
NO991910L
NO991910L NO991910A NO991910A NO991910L NO 991910 L NO991910 L NO 991910L NO 991910 A NO991910 A NO 991910A NO 991910 A NO991910 A NO 991910A NO 991910 L NO991910 L NO 991910L
Authority
NO
Norway
Prior art keywords
antiherpes
pharmaceutical composition
composition containing
containing acyclovir
topical applicators
Prior art date
Application number
NO991910A
Other languages
English (en)
Norwegian (no)
Other versions
NO991910D0 (no
Inventor
Giancarlo Santus
Roberto Golzi
Antonio Garavaglia
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO991910D0 publication Critical patent/NO991910D0/no
Publication of NO991910L publication Critical patent/NO991910L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO991910A 1996-10-31 1999-04-21 Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer NO991910L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002258A IT1287114B1 (it) 1996-10-31 1996-10-31 Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
PCT/EP1997/006022 WO1998018472A1 (en) 1996-10-31 1997-10-31 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators

Publications (2)

Publication Number Publication Date
NO991910D0 NO991910D0 (no) 1999-04-21
NO991910L true NO991910L (no) 1999-06-21

Family

ID=11375126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991910A NO991910L (no) 1996-10-31 1999-04-21 Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer

Country Status (13)

Country Link
EP (1) EP0948332B1 (it)
JP (1) JP2001503404A (it)
KR (1) KR20000052678A (it)
CN (1) CN1235547A (it)
AT (1) ATE248597T1 (it)
AU (1) AU724741B2 (it)
BR (1) BR9712610A (it)
CA (1) CA2270254A1 (it)
DE (1) DE69724647D1 (it)
IT (1) IT1287114B1 (it)
NO (1) NO991910L (it)
NZ (1) NZ335685A (it)
WO (1) WO1998018472A1 (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU3853800A (en) * 1999-01-11 2000-08-01 Ahmet Degirmenci Pharmaceutical forms and methods for penetration continuity
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20040091539A1 (en) * 2002-11-13 2004-05-13 Ake Lindahl Dermastick thickened ointment
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
CA2597525A1 (en) * 2005-02-17 2006-08-24 Senju Pharmaceutical Co., Ltd. Solid ophthalmic drug for external use
AU2006279602B2 (en) * 2005-08-17 2009-06-04 Elc Management Llc Delivery system for appetite suppressant
JP4013076B2 (ja) * 2005-09-30 2007-11-28 小林製薬株式会社 固形状の外用医薬組成物
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
DE102007061897A1 (de) * 2007-12-20 2009-06-25 Matthias Dr. Hempel Paraffinfreier Lippenpflegestift
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
ITMI20111747A1 (it) 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
CN103751100B (zh) * 2013-11-28 2015-09-16 郑州韩都药业集团有限公司 一种阿昔洛韦乳膏
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
GB201819418D0 (en) * 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
KR20220020911A (ko) * 2019-06-14 2022-02-21 프로펠라 쎄라퓨틱스, 인크. 국소 아시클로버 제형 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.

Also Published As

Publication number Publication date
ITMI962258A1 (it) 1998-05-01
ATE248597T1 (de) 2003-09-15
CN1235547A (zh) 1999-11-17
AU6907898A (en) 1998-05-22
BR9712610A (pt) 1999-12-21
CA2270254A1 (en) 1998-05-07
EP0948332A1 (en) 1999-10-13
NO991910D0 (no) 1999-04-21
KR20000052678A (ko) 2000-08-25
IT1287114B1 (it) 1998-08-04
AU724741B2 (en) 2000-09-28
DE69724647D1 (de) 2003-10-09
EP0948332B1 (en) 2003-09-03
JP2001503404A (ja) 2001-03-13
NZ335685A (en) 2000-03-27
WO1998018472A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
NO991910D0 (no) Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer
PT671161E (pt) Ectoina e derivados de ectoina como distribuidor de humidade em produtos cosmeticos
ES2119800T3 (es) Mejora de la penetracion de formulaciones de aplicacion topica.
ES2177673T3 (es) Uso de flavonoides como agentes inmunorreguladores o inmunoprotectoresen preparaciones cosmeticas y dermatologicas.
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1253431B (it) Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
DE69322251T2 (de) Medizinische zusammensetzung
IE781032L (en) Pharmaceutical compositions
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
DK0464297T3 (da) Komplekser af neolignanderivater med phospholipider, anvendelsen deraf samt farmaceutiske og kosmetiske formuleringer indeholdende disse
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
GR1001511B (el) Στεροειδείς συν?έσεις.
EP1269978A3 (de) Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
EP1055413A3 (de) Wirkstoffkombinationen aus sulfonierten UV-Filtersubstanzen und Flavonderivaten und/oder Flavanonderivaten, insbesondere von Flavonoiden sowie kosmetische Zubereitungen, solche Wirkstoffkombinationen enthaltend
EP1020192A3 (de) Anticellulitiszusammensetzung und ihre Verwendung
AU4040195A (en) Topical composition containing penciclovir
WO1993003720A3 (en) Methods and compositions for treating sunburns
DE50010067D1 (de) Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application